• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管计数及血管内皮生长因子的表达作为无淋巴结转移结肠癌的预后因素

Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer.

作者信息

Takahashi Y, Tucker S L, Kitadai Y, Koura A N, Bucana C D, Cleary K R, Ellis L M

机构信息

Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, USA.

出版信息

Arch Surg. 1997 May;132(5):541-6. doi: 10.1001/archsurg.1997.01430290087018.

DOI:10.1001/archsurg.1997.01430290087018
PMID:9161399
Abstract

BACKGROUND

The value of these prognostic factors was compared with that of other clinicopathologic factors such as tumor grade, tumor stage, mucin production, vascular invasion, perineural invasion, and lymphatic invasion.

OBJECTIVE

To determine whether the development of distant recurrence in patients with node-negative colon cancer could be predicted using vessel count and vascular endothelial growth factor (VEGF) expression.

DESIGN

Paraffin-embedded colon cancers were immunostained for factor VIII, VEGF, basic fibroblast growth factor, and proliferating cell nuclear antigen; slides were reviewed for differentiation, mucin production, and the presence of vascular, lymphatic, and/or perineural invasion.

SETTING

A large academic cancer referral center where 27 patients with node-negative colon cancer were operated on during 1988 and 1989.

MAIN OUTCOME MEASURE

The development of and interval to recurrence.

RESULTS

Eight patients developed liver, lung, or lymph node metastases at a median of 24 months. The median follow-up for patients without cancer recurrence was 60 months. The mean tumor vessel count for those patients who remained disease-free was significantly fewer than for those patients who suffered a recurrence (20 vs 33, respectively). By univariate analysis, 3 factors- perineural invasion, vessel count, and VEGF expression- were correlated with time to recurrence. By multivariate analysis, only vessel count was significantly related to differences in time to recurrence. Expression of VEGF correlated with vessel count.

CONCLUSION

Vessel count and expression of VEGF may be useful for predicting distant recurrence in patients with node-negative colon cancer.

摘要

背景

将这些预后因素的价值与其他临床病理因素进行比较,如肿瘤分级、肿瘤分期、黏液产生、血管侵犯、神经周围侵犯和淋巴侵犯。

目的

确定使用血管计数和血管内皮生长因子(VEGF)表达是否可以预测无淋巴结转移结肠癌患者远处复发的发生情况。

设计

对石蜡包埋的结肠癌进行免疫染色,检测因子VIII、VEGF、碱性成纤维细胞生长因子和增殖细胞核抗原;对切片进行评估,以确定分化程度、黏液产生情况以及是否存在血管、淋巴和/或神经周围侵犯。

地点

一家大型学术性癌症转诊中心,1988年至1989年期间对27例无淋巴结转移的结肠癌患者进行了手术。

主要观察指标

复发的发生情况及复发间隔时间。

结果

8例患者出现肝、肺或淋巴结转移,中位时间为24个月。无癌症复发患者的中位随访时间为60个月。无疾病复发患者的平均肿瘤血管计数明显少于复发患者(分别为20和33)。单因素分析显示,3个因素——神经周围侵犯、血管计数和VEGF表达——与复发时间相关。多因素分析显示,只有血管计数与复发时间的差异显著相关。VEGF表达与血管计数相关。

结论

血管计数和VEGF表达可能有助于预测无淋巴结转移结肠癌患者的远处复发。

相似文献

1
Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer.血管计数及血管内皮生长因子的表达作为无淋巴结转移结肠癌的预后因素
Arch Surg. 1997 May;132(5):541-6. doi: 10.1001/archsurg.1997.01430290087018.
2
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.血管内皮生长因子及其受体KDR的表达与人类结肠癌的血管生成、转移及增殖相关。
Cancer Res. 1995 Sep 15;55(18):3964-8.
3
Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.血管内皮生长因子蛋白在淋巴结阴性乳腺癌中的预后意义
J Natl Cancer Inst. 1997 Jan 15;89(2):139-47. doi: 10.1093/jnci/89.2.139.
4
VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.血管内皮生长因子(VEGF)、fms样酪氨酸激酶-1(flt-1)和激酶插入区受体/胎儿肝脏激酶-1(KDR/flk-1)作为子宫内膜癌的预后指标
Gynecol Oncol. 2000 Jan;76(1):33-9. doi: 10.1006/gyno.1999.5658.
5
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.血管内皮生长因子的表达可预测II期结肠癌的无事件生存期。
Clin Cancer Res. 2000 Jul;6(7):2803-7.
6
Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?血管内皮生长因子(VEGF)能否预测接受放疗的淋巴结阴性乳腺癌的局部复发和生存率?
Br J Cancer. 1999 Oct;81(4):727-32. doi: 10.1038/sj.bjc.6690755.
7
Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.淋巴结阳性结肠癌中血管内皮生长因子表达、S期分数及胸苷酸合成酶定量分析:与肿瘤复发及辅助化疗耐药性的关系
Ann Oncol. 2001 Feb;12(2):239-44. doi: 10.1023/a:1008339408300.
8
Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma.术前活检标本中血管内皮生长因子的表达与早期胃癌患者的疾病复发相关。
Cancer. 1999 Aug 15;86(4):566-71. doi: 10.1002/(sici)1097-0142(19990815)86:4<566::aid-cncr4>3.0.co;2-1.
9
p53, vessel count, and vascular endothelial growth factor expression in human colon cancer.人结肠癌中的p53、血管计数及血管内皮生长因子表达
Int J Cancer. 1998 Feb 20;79(1):34-8. doi: 10.1002/(sici)1097-0215(19980220)79:1<34::aid-ijc7>3.0.co;2-x.
10
High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma.血管内皮生长因子的高表达与导管腺癌患者的肝转移及预后不良相关。
Cancer. 2000 May 15;88(10):2239-45. doi: 10.1002/(sici)1097-0142(20000515)88:10<2239::aid-cncr6>3.0.co;2-v.

引用本文的文献

1
The interaction of platelet-related factors with tumor cells promotes tumor metastasis.血小板相关因子与肿瘤细胞的相互作用促进了肿瘤转移。
J Transl Med. 2024 Apr 18;22(1):371. doi: 10.1186/s12967-024-05126-6.
2
Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers.胃肠道和肝胆癌中当前及新兴的抗血管生成疗法
Front Oncol. 2022 Oct 10;12:1021772. doi: 10.3389/fonc.2022.1021772. eCollection 2022.
3
The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options.
胰腺癌中的细胞外基质:复杂网络的描述及有前景的治疗选择
Cancers (Basel). 2021 Sep 3;13(17):4442. doi: 10.3390/cancers13174442.
4
Angiogenesis-related non-coding RNAs and gastrointestinal cancer.血管生成相关的非编码RNA与胃肠道癌
Mol Ther Oncolytics. 2021 May 15;21:220-241. doi: 10.1016/j.omto.2021.04.002. eCollection 2021 Jun 25.
5
TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.TRF2 和 VEGF-A:与结直肠癌患者生存预后相关的未知关系。
J Exp Clin Cancer Res. 2020 Jun 15;39(1):111. doi: 10.1186/s13046-020-01612-z.
6
The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer.血清血管内皮生长因子(VEGF)与结直肠癌肿瘤VEGF受体3之间的相关性。
Ann Surg Treat Res. 2019 Jul;97(1):15-20. doi: 10.4174/astr.2019.97.1.15. Epub 2019 Jun 26.
7
Feline injection site sarcoma: immunohistochemical characteristics.猫注射部位肉瘤:免疫组织化学特征
J Feline Med Surg. 2019 Apr;21(4):314-321. doi: 10.1177/1098612X18774709. Epub 2018 May 23.
8
A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma.对肿瘤大小作为直肠腺癌预后变量的价值进行批判性重新评估。
J Cancer. 2017 Jul 4;8(10):1927-1934. doi: 10.7150/jca.17930. eCollection 2017.
9
Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives.转移性结直肠癌中贝伐单抗的聚焦:患者选择与展望
Gastrointest Cancer. 2016;6:21-30. doi: 10.2147/GICTT.S97740. Epub 2016 Jun 30.
10
Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion.与传统局部治疗相比,腔内输注贝伐单抗治疗恶性胸腔积液患者疗效更佳。
Oncotarget. 2017 May 23;8(21):35262-35271. doi: 10.18632/oncotarget.13064.